Market Size –
The multiomics market size has grown rapidly in recent years. It will grow from $2.78 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to Increased biomedical research, increased government and private funding, a rise in the prevalence of chronic diseases, technological advancements, and enhanced computational tools and software for data analysis.
The multiomics market size is expected to see rapid growth in the next few years. It will grow to $6.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to advances in artificial intelligence and machine learning, expansion of clinical applications, growing biopharmaceutical industry, emergence of integrated multiomics platforms, and increasing use in agricultural and environmental research. Major trends in the forecast period include technological advancements, the launch of new commerical multiomics platforms, the adoption of spatially resolved multiomics analysis, adoption in biopharmaceutical research and development, and expansion into clinical diagnostics.
Order your report now for swift delivery @
https://thebusinessresearchcompany.com/report/multiomics-global-market-report
Scope Of Multiomics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Multiomics Market Overview
Market Drivers –
The multiomics market size has grown rapidly in recent years. It will grow from $2.78 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to Increased biomedical research, increased government and private funding, a rise in the prevalence of chronic diseases, technological advancements, and enhanced computational tools and software for data analysis.
The multiomics market size is expected to see rapid growth in the next few years. It will grow to $6.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to advances in artificial intelligence and machine learning, expansion of clinical applications, growing biopharmaceutical industry, emergence of integrated multiomics platforms, and increasing use in agricultural and environmental research. Major trends in the forecast period include technological advancements, the launch of new commerical multiomics platforms, the adoption of spatially resolved multiomics analysis, adoption in biopharmaceutical research and development, and expansion into clinical diagnostics.
Market Trends –
The multiomics market covered in this report is segmented –
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users
Get an inside scoop of the multiomics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample_request?id=15866&type=smp
Regional Insights –
North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group
Table of Contents
1. Executive Summary
2. Multiomics Market Characteristics
3. Multiomics Market Trends And Strategies
4. Multiomics Market – Macro Economic Scenario
5. Global Multiomics Market Size and Growth
.
.
.
31. Multiomics Market Other Major And Innovative Companies
32. Global Multiomics Market Competitive Benchmarking
33. Global Multiomics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Multiomics Market
35. Multiomics Market Future Outlook and Potential Analysis
36.Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
